FDA Inspection
LE PAPILLON LTD.LE PAPILLON LTD. – FDA Inspection, Dec 20, 2018
Record Details
This FDA Inspection record concerns LE PAPILLON LTD., with an inspection on December 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d7890f9a-a680-45b7-9d2f-935b6e9031b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1075040
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.182Personnel dating/signing equipment log
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LE PAPILLON LTD.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
Other documents for LE PAPILLON LTD.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.